CHINA HK POWER discloses full utilisation of HK$10.88 million share-placement proceeds; sets out terms and valuation of 1.00 billion option grant to CEO

Bulletin Express
Sep 17

China HK Power Smart Energy Group Limited has issued supplemental information to its FY-2026 annual report, clarifying the deployment of share-placement proceeds and detailing a substantial, still-conditional option grant to Chief Executive Officer Mr. Deng Yaobo.

Share subscription under general mandate • On 10 June 2025 the company placed 43.70 million new shares at HK$0.25 each, raising net proceeds of HK$10.88 million. • All proceeds were expended by 31 March 2026 in line with prior disclosures: HK$9.56 million funded staff salaries and directors’ fees, while HK$1.32 million covered office rental and utilities. • The subscriber, Mr. Zeng Guo Bin, is an independent third party. The shares were issued on 16 July 2025 at a net price of HK$0.249 per share, versus a market close of HK$0.255 on the transaction date.

CEO option package • On 13 January 2026 the board conditionally approved a grant of 1.00 billion options to Mr. Deng under a specific mandate, equal to 13.45% of the company’s issued share capital at the grant date. • Exercise price: HK$0.482; closing market price on grant date: HK$0.470. Option life: ten years to 12 January 2036. • Vesting is split into three tranches (30% / 30% / 40%) across 2028-2030, each contingent on audited net-profit turn-around or maintenance targets and market-capitalisation hurdles (≥30 % growth for the first tranche; ≤10 % decline thresholds for subsequent tranches). • An independent valuer applied a Binomial model with Monte Carlo simulation, estimating aggregate fair value at HK$74.57 million. Only the third tranche (400 million options) carries a non-zero fair value (HK$0.1864 each) given current probability assessments; the first two tranches were assigned nil value. • The grant remains subject to Hong Kong Stock Exchange clearance and independent shareholders’ approval at an extraordinary general meeting; no options had vested or become exercisable by 31 March 2026.

Potential dilution and mandate status • If fully exercised, options outstanding under all company schemes—including the proposed CEO grant—would represent approximately 21.04 % of the weighted-average issued shares for FY-2026. • As the CEO options fall outside the existing share-option scheme, they do not consume the scheme’s mandate limit but will require separate independent-shareholder approval in accordance with Listing Rules 17.03C(3), 17.03D(1) and 17.07A.

Board and committee oversight The remuneration committee and the board have endorsed the performance-conditioned structure of the CEO grant, asserting alignment with shareholder interests. Independent non-executive directors’ views will be provided in the forthcoming circular for the EGM.

The board confirmed that the supplemental disclosures do not affect other information in the FY-2026 annual report.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10